affected by healthcare-associated infections (HAIs). The main types of HAIs are respiratory tract infections (31.2%), urinary tract infections (31.2%) and skin infections (22.8%) (5) .
Among the major non-communicable diseases, cancer is a leading cause of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer-related deaths in 2012 (9, 11). It is expected that annual cancer cases will rise from 14 million in 2012 to 22 million within the next 2 decades (1). Specific infections are recognized as a major cause of cancer, with an estimated 2 million (16.1%) of the 12.7 million new cases of cancer in 2008 attributable to infection (11). The most important infectious agents are Helicobacter pylori, Hepatitis B and C viruses and Human papillomaviruses, which together are responsible for 1.9 million cases of gastric, liver and cervix uteri cancers, respectively (1) . In addition to these infectious agents, Opisthorchis viverrini, Clonorchis sinensis, Epstein-Barr virus, human T-cell lymphotropic virus type 1, human herpes virus type 8 (known as Kaposi's sarcoma herpes virus) and Schistosoma haematobium are classified as carcinogenic to humans.
As a reference to the significance of the infectious diseases nowadays, in this current issue of the journal, T. Kostadinova (7) and E. Kovachev (8) are focusing on two medically important microbial agents -Chlamydia trachomatis and Epstein-Barr virus. T. Kostadinova presents the current knowledge about the mechanisms of EBV pathogenesis in humans and its oncogenic potential. E. Kovachev reveals the relationship between Chlamydia trachomatis infection and pregnancy complications.
In conclusion, in the next decade the infectious diseases (incl. new and re-emergence of old infectious diseases) are expected to remain a serious challenge for detection and monitoring, prevention, control and adequate treatment.
